CLINICAL_TRIALS
trial_result
· 2019-01-30
Clinical Trial Update: Safety and Efficacy of Albuterol Administered by the Halix™ Dry Powder Inhaler in Subjects With Asthma [Phase 2]
Summary
A Phase 2 trial evaluated the safety and efficacy of albuterol delivered by the Halix dry powder inhaler in adults with asthma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Concentrx Pharmaceuticals, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED